Insight | D. Boral Capital

Featured Insights

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

January 21, 2025

D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor

January 16, 2025

D. Boral Capital Served as Co-Placement Agent to Kairos Pharma, Ltd. In connection with its $3.5 Million Private Placement

January 14, 2025

D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

January 13, 2025

D. Boral Capital Served as Placement Agent to Nature’s Miracle Holding, Inc. with its up to $29.7 Million Financing

January 6, 2025

D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

Left 1 2 3 4 5 … 9 Right

December 17, 2024

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

January 16, 2025

D. Boral Capital Served as Co-Placement Agent to Kairos Pharma, Ltd. In connection with its $3.5 Million Private Placement

January 14, 2025

D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

January 13, 2025

D. Boral Capital Served as Placement Agent to Nature’s Miracle Holding, Inc. with its up to $29.7 Million Financing

January 6, 2025

D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

December 30, 2024

D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering

Left 1 2 3 4 5 … 8 Right

Insights

Featured Insights

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital Secures Strategic Investments from Global Investment Bank ARC Group and an Institutional Investor

D. Boral Capital Served as Co-Placement Agent to Kairos Pharma, Ltd. In connection with its $3.5 Million Private Placement

D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

D. Boral Capital Served as Placement Agent to Nature’s Miracle Holding, Inc. with its up to $29.7 Million Financing

D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital Served as Co-Placement Agent to Kairos Pharma, Ltd. In connection with its $3.5 Million Private Placement

D. Boral Capital Served as the Sole Underwriter on the IPO of BurTech Acquisition Corp (Nasdaq: BRKH) which Recently Completed an ~$894 Million Business Combination with Blaize, Inc. (“Blaize”)

D. Boral Capital Served as Placement Agent to Nature’s Miracle Holding, Inc. with its up to $29.7 Million Financing

D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

D. Boral Capital Served as Underwriter to Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) in connection with its $4.8 Million Initial Public Offering

Recent Transactions

January 13, 2025

Nature’s Miracle Holding, Inc.

$29,700,000

January 6, 2025

HWH International Inc.

$1,765,900

December 30, 2024

Park Ha Biological Technology Co., Ltd.

$4,800,000

December 23, 2024

FibroBiologics, Inc.

$25,000,000

December 19, 2024

Webuy Global Ltd.

$3,700,000

December 16, 2024

FAVO Capital, Inc.

$2,000,000

Follow Us